CompletedNCT07008209
Official study titleComparing the Effects of Reconstrual and Repurposing Reappraisal Strategies on Sadness and Anxiety in Emerging Adults: A Brief Intervention
This study has finished and is no longer accepting participants.
In IstanbulAnxiety, DepressionBehavioural studyAges 18–30
- Countries
- Türkiye
- Sponsor
- Ibn Haldun University
CompletedNCT01565629
This study has finished and is no longer accepting participants.
In St. PetersburgAnxiety, OCDBehavioural studyAges 7–12
- Countries
- United States
- Sponsor
- University of South Florida
CompletedNCT05573672
Official study titleDietary Counselling Plus Omega-3 Supplementation in the Treatment of Generalized Anxiety Disorder: A Randomized Wait-list Controlled Pilot Trial
This study has finished and is no longer accepting participants.
In TorontoAnxietyInterventional studyAges 18–65
- Countries
- Canada
- Sponsor
- The Canadian College of Naturopathic Medicine
CompletedNCT05375851
Official study titleDigital Interventions As an Add-on Tool in Generalized Anxiety Disorder Treatment: a Randomized Clinical Trial
This study has finished and is no longer accepting participants.
In Porto AlegreAnxietyMedication studyAges 18+
- Countries
- Brazil
- Sponsor
- Hospital de Clinicas de Porto Alegre
CompletedNCT02066792
This study has finished and is no longer accepting participants.
Multiple locations, including ChicagoAnxietyMedication studyAges 18–70
- Countries
- United States
- Sponsor
- Jasper A. Smits
CompletedNCT01243606
This study has finished and is no longer accepting participants.
In BostonAnxietyBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Boston University Charles River Campus
CompletedNCT06510504
What is this study about?Researchers compared 225 mg BNC210 and placebo, tracking side effects to assess safety in adults with an anxiety condition.
This study has finished and is no longer accepting participants.
Multiple locations, including EncinoAnxietyMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Bionomics Limited
CompletedNCT04850989
What is this study about?This study evaluated the effectiveness of virtual reality therapy for people with anxiety.
This study has finished and is no longer accepting participants.
In University ParkAnxietyDevice studyAges 18+
- Countries
- United States
- Sponsor
- Penn State University
CompletedNCT05749055
What is this study about?Researchers compared ENX-102 and placebo, tracking side effects to assess safety in people with an anxiety condition.
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixAnxietyMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Engrail Therapeutics INC
CompletedNCT00517244
Official study titleChild Anxiety Disorders: Parenting and Temperament Effects
This study has finished and is no longer accepting participants.
In ProvidenceAnxiety, OCDObservational studyAges 8–12
- Countries
- United States
- Sponsor
- Rhode Island Hospital
Active Not RecruitingNCT06358651
Official study titleUS, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of Fasedienol Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder, With an Open-Label Extension (PALISADE-3)
This study is no longer accepting new participants.
Multiple locations, including PhoenixAnxietyMedication studyAges 18–65
- Countries
- United States
- Sponsor
- VistaGen Therapeutics, Inc.
Active Not RecruitingNCT04760275
Official study titleA Sequential Multiple Assignment Randomized Trial (SMART) Assessing Medication and CBT Sequencing Strategies in the Treatment of Predominantly Ethnic Minority, Underserved Youth With Anxiety Disorders
This study is no longer accepting new participants.
In Los AngelesAnxietyMedication studyAges 8–17
- Countries
- United States
- Sponsor
- Children's Hospital Los Angeles